AI Science Tracker
EN

LightGBM estimates treatment-machine leaf errors in separate patient plans

Shahid Beheshti University; Shahid Beheshti University of Medical Sciences; Tehran University of Medical Sciences; Amirkabir University of Technology · 27 Oct 2026 · medicine

Discovery

LightGBM estimates treatment-machine leaf errors in separate patient plans

Source check: Source checked. Not independent scientific confirmation.

Finding: A LightGBM model predicted logged multi-leaf collimator position errors in radiotherapy plans from previously unseen patients. Six held-out plans had mean absolute error 0.054 mm; nine additional patient plans supported dose-recalculation agreement. These are machine-log and calculated-dose validation results, with no measured patient benefit or independent physical dose validation.

Technology: LightGBM gradient-boosted decision trees

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
LightGBM learned plan/mechanical/initialization features to estimate delivered leaf-position errors; predicted positions enabled patient-plan dose recalculations compared with log-derived delivery estimates.
Test and result
Twenty-nine patient plans were split by patient/plan into 23 development and six held-out test plans. GroupKFold tuning and development-only feature selection preceded final fitting. Against delivered-position machine logs, test MAE was 0.054 mm and RMSE 0.144 mm. Nine further patients supplied independent plans over six fractions; predicted and logged leaf positions were separately inserted into plans for dose recalculation on patient CTs. Agreement concerns reconstructed dose distributions, not in-vivo measured dose.
Limitation / still unknown
Single treatment center and accelerator; many leaf/control-point observations derive from few patients. Machine logs are the position reference and both dose distributions use the same dose-calculation system, so no independent physical dosimetry or outcome benefit is established. Dosimetric deviations were small and gamma agreement already high for delivered plans; the study does not establish detection of clinically dangerous failures or safer treatment.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13714354/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Read actual primary patient/plan partition, signed-error/log reference, LightGBM tuning/feature selection, separate nine-patient dosimetric Methods, Results and limitations. Original article-meta online October27 is distinguished from November collection date. Supplementary raw logs were not independently inspected. Exact primary identity/date and fresh primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.